Invesco »

Sab Biotherapeutics shares owned by Invesco

Quarter-by-quarter ownership of Sab Biotherapeutics (SABS) shares owned by Invesco from 13F filings

Historical chart of Invesco investment in Sab Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sab Biotherapeutics held by Invesco consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sab Biotherapeutics by Invesco

Quarter filed Position value Share count Share price at filing
2026-06-30 $88k 23k 3.90

More positions owned by Invesco

NVIDIA Corporation (NVDA)
Apple (AAPL)
Micron Technology (MU)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Advanced Micro Devices (AMD)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Lam Research Corp Com New (LRCX)
Intel Corporation (INTC)
Meta Platforms Cl A (META)
Applied Materials (AMAT)
Wal-Mart Stores (WMT)

View all positions for Invesco

Top funds holding Sab Biotherapeutics

Caligan Partners
Vivo Capital
Perceptive Advisors
Adage Capital Partners GP
RA Capital Management
Balyasny Asset Management
BlackRock
Vanguard Capital Management
Commodore Capital
Millennium Management
Spruce Street Capital
Sessa Capital IM
Affinity Asset Advisors
Boothbay Fund Management
Geode Capital Management

View all funds holding Sab Biotherapeutics